| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| DESLANOSIDE DISCONTINUED
| DESLANOSIDE | CARDIOVASCULAR | INJECTION | HT 51 HOUR (PMID6168847) | SODIUM/POTASSIUM ATPASE | SODIUM/POTASSIUM-TRANSPORTING ATPASE INHIBITOR CHEMBL2095186 SODIUM/POTASSIUM-TRANSPORTING ATPASE P05023 SODIUM/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1 HOMO SAPIENS ENZYME HYDROLASE | EMA | |||
